Sarepta Therapeutics SRPT
NASDAQ SRPT
$18.28 -0.28 (-1.51%)
As of: Oct 22, 2026 · 2:32 PM EDT

Sarepta Therapeutics (SRPT) Short-Term Debt issuances (2026)

Updated

Sarepta Therapeutics (SRPT) recorded Short-Term Debt issuances of $175 million in Q2 2026, down 30.0% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Short-Term Debt issuances (2026) Analysis & Trends

On a TTM basis, Sarepta Therapeutics' Short-Term Debt issuances came in at $425 million as of Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,167.12 Bn 1,135.70 Bn 19.71 Bn -
2 Johnson & Johnson 647.48 Bn 567.35 Bn 17.30 Bn 2.28 Bn
3 AbbVie 502.73 Bn 475.84 Bn 12.70 Bn -
4 Merck 363.86 Bn 318.23 Bn 12.21 Bn -
5 Novartis Ag 303.31 Bn 267.30 Bn 11.24 Bn -
6 Astrazeneca 269.08 Bn 242.77 Bn 12.86 Bn -
7 Amgen 242.07 Bn 197.46 Bn 7.24 Bn -
8 Gilead Sciences 194.93 Bn 169.12 Bn 6.22 Bn -
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn -
10 Sarepta Therapeutics 1.92 Bn -1.31 Bn 251.87 Mn 175.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 175.00 Mn
Mar 31, 2026 250.00 Mn
API Access

Sarepta Therapeutics Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=SRPT&period=max&api_key=YOUR_API_KEY